Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Vitamin B12 in Septic Shock
NCT03783091Phase 2Completed
- Sponsor
- Medical College of Wisconsin
- Start
- Aug 2019
- Primary completion
- Feb 2023
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxocobalamin in septic shock, sponsored by Medical College of Wisconsin. Started Aug 2019; status: completed.
02
Drugs
hydroxocobalamin
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT03783091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03783091.